temozolomide has been researched along with Benign Cerebellar Neoplasms in 32 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report results of a phase I/II evaluating vismodegib + temozolomide (TMZ) in immunohistochemically defined SHH recurrent/refractory adult medulloblastoma." | 9.41 | MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. ( Barritault, M; Bidaux, AS; Bonneville-Levard, A; Chinot, O; Frappaz, D; Garin, G; Hottinger, AF; Laigle-Donadey, F; Le Rhun, E; Meyronnet, D; Montané, L; Pérol, D, 2021) |
| "The aim of this study was to assess the objective response rate (ORR) of children and young adults with recurrent medulloblastoma/primitive neuroectodermal tumor (MB/PNET) treated with temozolomide (TMZ)." | 9.19 | Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. ( Abate, ME; Barone, G; Cefalo, G; Colosimo, C; Garrè, ML; Madon, E; Mascarin, M; Massimino, M; Perilongo, G; Potepan, P; Riccardi, R; Ridola, V; Ruggiero, A; Spreafico, F, 2014) |
| "This multicenter phase II study investigated temozolomide + irinotecan (TEMIRI) treatment in children with relapsed or refractory medulloblastoma." | 9.17 | Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study. ( Aerts, I; Bailey, S; Breazna, A; Cañete, A; Cisar, L; de Toledo Codina, JS; Dorman, A; Estlin, E; Geoerger, B; Gesner, L; Grill, J; Grundy, RG; Hargrave, D; Leblond, P; Madero, L; Nicolin, G; Perek, D; Verlooy, J, 2013) |
| " In this study, we utilized severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma to study the effect of HNG in Temozolomide (TMZ) induced male germ cell apoptosis and white blood cell (WBC) suppression." | 7.91 | The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma. ( Dai-Ju, J; Jia, Y; Lasky, JL; Lue, Y; Panosyan, EH; Swerdloff, RS; Wang, C, 2019) |
| "Case report of a 77-year-old woman with a radiation-induced, high-grade cerebellar glioma that responded durably to temozolomide." | 7.74 | Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide. ( Doherty, LM; Drappatz, J; Kesari, S; Monje, ML; Ramakrishna, NR; Wen, PY; Young, G, 2007) |
| " We report results of a phase I/II evaluating vismodegib + temozolomide (TMZ) in immunohistochemically defined SHH recurrent/refractory adult medulloblastoma." | 5.41 | MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. ( Barritault, M; Bidaux, AS; Bonneville-Levard, A; Chinot, O; Frappaz, D; Garin, G; Hottinger, AF; Laigle-Donadey, F; Le Rhun, E; Meyronnet, D; Montané, L; Pérol, D, 2021) |
| "Treatment with temozolomide resulted in relief of clinical symptoms and stabilization of tumour growth for 8 months." | 5.34 | Metastatic medulloblastoma in an adult; treatment with temozolomide. ( Bernsen, HJ; Poelen, J; Prick, MJ, 2007) |
| "Temozolomide is an oral cytotoxic agent that has demonstrated its interest in high grade glioma tumors." | 5.34 | Temozolomide treatment of an adult with a relapsing medulloblastoma. ( Bay, JO; Durando, X; Gilliot, O; Irthum, B; Thivat, E; Verrelle, P; Vincent, C, 2007) |
| "The aim of this study was to assess the objective response rate (ORR) of children and young adults with recurrent medulloblastoma/primitive neuroectodermal tumor (MB/PNET) treated with temozolomide (TMZ)." | 5.19 | Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. ( Abate, ME; Barone, G; Cefalo, G; Colosimo, C; Garrè, ML; Madon, E; Mascarin, M; Massimino, M; Perilongo, G; Potepan, P; Riccardi, R; Ridola, V; Ruggiero, A; Spreafico, F, 2014) |
| "This multicenter phase II study investigated temozolomide + irinotecan (TEMIRI) treatment in children with relapsed or refractory medulloblastoma." | 5.17 | Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study. ( Aerts, I; Bailey, S; Breazna, A; Cañete, A; Cisar, L; de Toledo Codina, JS; Dorman, A; Estlin, E; Geoerger, B; Gesner, L; Grill, J; Grundy, RG; Hargrave, D; Leblond, P; Madero, L; Nicolin, G; Perek, D; Verlooy, J, 2013) |
| " In this study, we utilized severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma to study the effect of HNG in Temozolomide (TMZ) induced male germ cell apoptosis and white blood cell (WBC) suppression." | 3.91 | The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma. ( Dai-Ju, J; Jia, Y; Lasky, JL; Lue, Y; Panosyan, EH; Swerdloff, RS; Wang, C, 2019) |
| "We have investigated on the potentiation of etoposide (ETP) and temozolomide (TMZ) cytotoxicity in U-87MG glioblastoma and D283 medulloblastoma cell lines by curcumin (CUR) and turmeric force (TF), a nutraceutical formulation of turmeric, with the objective of assessing the potential for their adjuvant use in brain tumor chemotherapy." | 3.78 | Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines. ( Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C, 2012) |
| "Methionine depletion causes a demonstrable increase in glutathione levels for medulloblastoma (Daoy) and glioma (D54) cells, with a decrease in MGMT activity for Daoy cells." | 3.75 | Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines. ( Estlin, EJ; McGown, A; Najim, N; Podmore, ID, 2009) |
| "Case report of a 77-year-old woman with a radiation-induced, high-grade cerebellar glioma that responded durably to temozolomide." | 3.74 | Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide. ( Doherty, LM; Drappatz, J; Kesari, S; Monje, ML; Ramakrishna, NR; Wen, PY; Young, G, 2007) |
| "Low-grade gliomas (e." | 1.39 | Cerebellar anaplastic astrocytoma in an adult with neurofibromatosis type 1: case report and review of literature. ( Brokinkel, B; Ewelt, C; Hargus, G; Heindel, W; Holling, M; Schober, O; Stummer, W; Wölfer, J, 2013) |
| "The temozolomide was stopped and the lymphoma was successfully treated with chemotherapy." | 1.38 | Non-Hodgkin's lymphoma in a patient on treatment with temozolomide. ( Otty, Z; Sabesan, S, 2012) |
| "In seven MB/PNET cell lines investigated, MGMT promoter methylation was detected only in D425 human MB cells as assayed by the qualitative methylation-specific PCR and the more quantitative pyrosequencing assay." | 1.37 | Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma. ( Arnold, L; Faoro, D; Gerber, NU; Grotzer, MA; Haybaeck, J; Hegi, M; Hürlimann, ML; Mittelbronn, M; Rutkowski, S; Sciuscio, D; Shalaby, T; von Bueren, AO, 2011) |
| "Primitive neuroectodermal tumors (PNET) originating within the spinal cord are extraordinarily rare." | 1.37 | Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse. ( Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L, 2011) |
| "Treatment with temozolomide resulted in relief of clinical symptoms and stabilization of tumour growth for 8 months." | 1.34 | Metastatic medulloblastoma in an adult; treatment with temozolomide. ( Bernsen, HJ; Poelen, J; Prick, MJ, 2007) |
| "Temozolomide is an oral cytotoxic agent that has demonstrated its interest in high grade glioma tumors." | 1.34 | Temozolomide treatment of an adult with a relapsing medulloblastoma. ( Bay, JO; Durando, X; Gilliot, O; Irthum, B; Thivat, E; Verrelle, P; Vincent, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 22 (68.75) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Tian, F | 1 |
| Chen, X | 1 |
| Frappaz, D | 1 |
| Barritault, M | 1 |
| Montané, L | 1 |
| Laigle-Donadey, F | 1 |
| Chinot, O | 1 |
| Le Rhun, E | 1 |
| Bonneville-Levard, A | 1 |
| Hottinger, AF | 1 |
| Meyronnet, D | 1 |
| Bidaux, AS | 1 |
| Garin, G | 1 |
| Pérol, D | 1 |
| Bautista, F | 1 |
| Fioravantti, V | 1 |
| de Rojas, T | 1 |
| Carceller, F | 1 |
| Madero, L | 2 |
| Lassaletta, A | 1 |
| Moreno, L | 1 |
| Qin, Y | 1 |
| Zhang, HB | 1 |
| Ke, CS | 1 |
| Huang, J | 1 |
| Wu, B | 1 |
| Wan, C | 1 |
| Yang, CS | 1 |
| Yang, KY | 1 |
| Jia, Y | 1 |
| Lue, Y | 1 |
| Swerdloff, RS | 1 |
| Lasky, JL | 1 |
| Panosyan, EH | 1 |
| Dai-Ju, J | 1 |
| Wang, C | 1 |
| Massimino, M | 2 |
| Casanova, M | 1 |
| Polastri, D | 1 |
| Biassoni, V | 1 |
| Modena, P | 1 |
| Pecori, E | 1 |
| Schiavello, E | 1 |
| De Pava, MV | 1 |
| Indini, A | 1 |
| Rampini, P | 1 |
| Bauer, D | 1 |
| Catania, S | 1 |
| Podda, M | 1 |
| Gandola, L | 1 |
| Brokinkel, B | 1 |
| Schober, O | 1 |
| Ewelt, C | 1 |
| Heindel, W | 1 |
| Hargus, G | 1 |
| Stummer, W | 1 |
| Holling, M | 1 |
| Wölfer, J | 1 |
| Grill, J | 1 |
| Geoerger, B | 1 |
| Gesner, L | 1 |
| Perek, D | 1 |
| Leblond, P | 1 |
| Cañete, A | 1 |
| Aerts, I | 1 |
| de Toledo Codina, JS | 1 |
| Verlooy, J | 1 |
| Estlin, E | 1 |
| Cisar, L | 1 |
| Breazna, A | 1 |
| Dorman, A | 1 |
| Bailey, S | 1 |
| Nicolin, G | 1 |
| Grundy, RG | 2 |
| Hargrave, D | 1 |
| Takeshi, N | 1 |
| Kazuhiko, S | 1 |
| Koji, I | 1 |
| Toshikazu, H | 1 |
| Kaoru, K | 1 |
| Cefalo, G | 1 |
| Ruggiero, A | 2 |
| Barone, G | 1 |
| Ridola, V | 1 |
| Spreafico, F | 1 |
| Potepan, P | 1 |
| Abate, ME | 1 |
| Mascarin, M | 1 |
| Garrè, ML | 1 |
| Perilongo, G | 1 |
| Madon, E | 1 |
| Colosimo, C | 2 |
| Riccardi, R | 2 |
| Othman, RT | 1 |
| Kimishi, I | 1 |
| Bradshaw, TD | 1 |
| Storer, LC | 1 |
| Korshunov, A | 1 |
| Pfister, SM | 1 |
| Kerr, ID | 1 |
| Coyle, B | 1 |
| Pezuk, JA | 1 |
| Valera, ET | 1 |
| Delsin, LE | 1 |
| Scrideli, CA | 1 |
| Tone, LG | 1 |
| Brassesco, MS | 1 |
| Bonney, PA | 1 |
| Santucci, JA | 1 |
| Maurer, AJ | 1 |
| Sughrue, ME | 1 |
| McNall-Knapp, RY | 1 |
| Battiste, JD | 1 |
| Najim, N | 1 |
| Podmore, ID | 1 |
| McGown, A | 1 |
| Estlin, EJ | 1 |
| Rizzo, D | 1 |
| Attinà, G | 1 |
| Lazzareschi, I | 1 |
| Mastrangelo, S | 1 |
| Maurizi, P | 1 |
| Migliorati, R | 1 |
| Bertolini, P | 1 |
| Pastore, M | 1 |
| Faoro, D | 1 |
| von Bueren, AO | 2 |
| Shalaby, T | 1 |
| Sciuscio, D | 1 |
| Hürlimann, ML | 1 |
| Arnold, L | 1 |
| Gerber, NU | 1 |
| Haybaeck, J | 1 |
| Mittelbronn, M | 1 |
| Rutkowski, S | 2 |
| Hegi, M | 1 |
| Grotzer, MA | 2 |
| Gollard, RP | 1 |
| Rosen, L | 1 |
| Anson, J | 1 |
| Mason, J | 1 |
| Khoury, J | 1 |
| Komatsu, F | 1 |
| Kawaguchi, H | 1 |
| Tsugu, H | 1 |
| Oshiro, S | 1 |
| Komatsu, M | 1 |
| Fukushima, T | 1 |
| Nabeshima, K | 1 |
| Inoue, T | 1 |
| Chadarévian, JP | 1 |
| Legido, A | 1 |
| Halligan, GE | 1 |
| Faerber, EN | 1 |
| Piatt, JH | 1 |
| Morrissette, JD | 1 |
| Ara, J | 1 |
| Grant, ML | 1 |
| Katsetos, CD | 1 |
| Hsieh, MS | 1 |
| Ho, JT | 1 |
| Lin, LW | 1 |
| Tu, PH | 1 |
| Perry, A | 1 |
| Huang, AP | 1 |
| Sun, P | 1 |
| Liu, Y | 1 |
| Ying, H | 1 |
| Li, S | 1 |
| Otty, Z | 1 |
| Sabesan, S | 1 |
| Ramachandran, C | 1 |
| Nair, SM | 1 |
| Escalon, E | 1 |
| Melnick, SJ | 1 |
| Bacolod, MD | 1 |
| Hagel, C | 1 |
| Heinimann, K | 1 |
| Fedier, A | 1 |
| Kordes, U | 1 |
| Pietsch, T | 1 |
| Koster, J | 1 |
| Friedman, HS | 1 |
| Marra, G | 1 |
| Kool, M | 1 |
| Khoo, HM | 1 |
| Kishima, H | 1 |
| Kinoshita, M | 1 |
| Goto, Y | 1 |
| Kagawa, N | 1 |
| Hashimoto, N | 1 |
| Maruno, M | 1 |
| Yoshimine, T | 1 |
| Zheludkova, OG | 1 |
| Tarasova, IS | 1 |
| Gorbatykh, SV | 1 |
| Belogurova, MB | 1 |
| Kumirova, EV | 1 |
| Borodina, ID | 1 |
| Prityko, AG | 1 |
| Melikian, AG | 1 |
| Shcherbenko, OI | 1 |
| DeAngelis, LM | 1 |
| Koch, HJ | 1 |
| Roeber, S | 1 |
| Zimmermann, UW | 1 |
| Schäfer, C | 1 |
| Villarrubia, V | 1 |
| Kuchelmeister, K | 1 |
| Schachenmayr, W | 1 |
| Bogdahn, U | 1 |
| Steinbrecher, A | 1 |
| Monje, ML | 1 |
| Ramakrishna, NR | 1 |
| Young, G | 1 |
| Drappatz, J | 1 |
| Doherty, LM | 1 |
| Wen, PY | 1 |
| Kesari, S | 1 |
| Poelen, J | 1 |
| Bernsen, HJ | 1 |
| Prick, MJ | 1 |
| Durando, X | 1 |
| Thivat, E | 1 |
| Gilliot, O | 1 |
| Irthum, B | 1 |
| Verrelle, P | 1 |
| Vincent, C | 1 |
| Bay, JO | 1 |
| Rao, RD | 1 |
| Robins, HI | 1 |
| Mehta, MP | 1 |
2 reviews available for temozolomide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neop | 2017 |
Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellum; Child, Preschool; Dacarbazine; | 2012 |
5 trials available for temozolomide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Cost-Effectiveness Analysis of a Three-Drug Regimen Containing Bevacizumab for the Treatment of Recurrent Pediatric
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cerebellar Neoplasms; | 2022 |
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
Topics: Anilides; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Medulloblastoma; Pyridines; Temozolomide | 2021 |
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cerebellar Neoplasms; Chil | 2013 |
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Child; Child, Preschool; | 2014 |
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplas | 2010 |
25 other studies available for temozolomide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Primary extraskeletal myxoid chondrosarcoma in cerebellum: A case report with literature review.
Topics: Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellum; Chemoradiotherapy, Adjuv | 2017 |
The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cerebellar Neoplasms; Human | 2019 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemot | 2013 |
Cerebellar anaplastic astrocytoma in an adult with neurofibromatosis type 1: case report and review of literature.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Combined Modality Therapy; Dac | 2013 |
A case of adult onset medulloblastoma during maintenance chemotherapy for anaplastic astrocytoma one year after radiotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemor | 2013 |
Overcoming multiple drug resistance mechanisms in medulloblastoma.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cells, | 2014 |
The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Caspases; Cell Line, Tumor; Cel | 2015 |
Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Cerebella | 2016 |
Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Proliferation; Cerebellar Neop | 2009 |
Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; C | 2011 |
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuva | 2011 |
Radiation-induced astrocytoma with rapid malignant transformation: case report.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Basal Ganglia; Brain Neoplasms; Cell Transformation, | 2011 |
Cerebellar anaplastic pilocytic astrocytoma in a patient of neurofibromatosis type-1: case report and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Chemoradiotherapy; Dacarbazine | 2012 |
Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Bucladesine; Bystander Effect; Cell Line, Tumor; Cell Survival; Cere | 2012 |
Non-Hodgkin's lymphoma in a patient on treatment with temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Chemoradiotherapy; Dacarbazine; Gliob | 2012 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 2012 |
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cerebella | 2012 |
Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Dacarbazine; Ependymoma | 2013 |
[Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Bra | 2002 |
Chemotherapy for brain tumors--a new beginning.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 2005 |
[Spinal and cerebral leptomeningeal seeding from a melanocytoma of the cerebello-pontine angle].
Topics: Administration, Oral; Adult; Antineoplastic Agents, Alkylating; Arachnoid; Cerebellar Diseases; Cere | 2005 |
Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Dacarbazine | 2007 |
Metastatic medulloblastoma in an adult; treatment with temozolomide.
Topics: Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Dacarbazine; Female; Humans; Magneti | 2007 |
Temozolomide treatment of an adult with a relapsing medulloblastoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Dacarbazine; Humans; Magnetic Resona | 2007 |
Late recurrence of a primitive neuro-ectodermal tumor.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Cerebellar Neopla | 2001 |